Adverse drug events and the associated factors in patients with chronic Chagas disease

Adverse drug events and the associated factors in patients with chronic Chagas disease

Abstract INTRODUCTION: Herein, we aimed to identify the factors associated with adverse drug events (ADEs) in chronic Chagas disease (CD) patients. METHODS: We analyzed 320 medical notes from 295 patients. The Naranjo algorithm was applied to determine the cause of ADEs. Mixed effects logistic r...

Full description

Bibliographic Details
Main Authors:	Luiza Braz da Cunha Lopes, Raquel Rodrigues Pereira, Patricia Mello Andrade, Fernanda Martins Carneiro, Mauro Felippe Felix Mediano, Sophia Isabel Linnemann Kilgore, Alejandro Marcel Hasslocher-Moreno, Andréa Silvestre de Sousa, Manoel Marques Evangelista Oliveira, Roberto Magalhães Saraiva, Marcelo Teixeira de Holanda, Gilberto Marcelo Sperandio da Silva
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2020-04-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Chagas disease Adverse drug event Cardiomyopathy
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822020000100639&tlng=en

Similar Items

Exploring the Historical Background and Clinical Implications of Electrocardiogram in the Context of Chagas Disease Research
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2023-12-01)

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
by: Paula Simplício da Silva, et al.
Published: (2017-06-01)

Chagas heart disease is associated with decreased physical activity levels: A cross-sectional analysis
by: Leonardo Gonçalves Ribeiro, et al.
Published: (2024-06-01)

Inspiratory Muscle Strength in Chagas Cardiomyopathy: A Systematic Scoping Review
by: Flavia Mazzoli-Rocha, et al.
Published: (2023-12-01)

Two-dimensional strain derived parameters provide independent predictors of progression to Chagas cardiomyopathy and mortality in patients with Chagas disease
by: Roberto M. Saraiva, et al.
Published: (2022-02-01)

Effect of an exercise-based cardiac rehabilitation program on quality of life of patients with chronic Chagas cardiomyopathy: results from the PEACH randomized clinical trial
by: Marcelo Carvalho Vieira, et al.
Published: (2024-04-01)

Chagas disease mortality during the coronavirus disease 2019 pandemic: A Brazilian referral center experience
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2022-02-01)

Biomakers in Chronic Chagas Cardiomyopathy
by: Angela Braga Rodrigues, et al.
Published: (2022-08-01)

Agreement between upper endoscopy and esophagography in the diagnosis of megaesophagus in Chagas disease
by: Fernando de Barros, et al.
Published: (2019-03-01)

Impact of COVID-19 In-hospital Mortality in Chagas Disease Patients
by: Gilberto Marcelo Sperandio da Silva, et al.
Published: (2022-05-01)

Corrigendum: Impact of COVID-19 in-hospital mortality in chagas disease patients
by: Gilberto Marcelo Sperandio da Silva, et al.
Published: (2022-07-01)

Exercise tests in Chagas cardiomyopathy: an overview of functional evaluation, prognostic significance, and current challenges
by: Henrique Silveira Costa, et al.
Published: (2020-07-01)

Temporal changes in the clinical-epidemiological profile of patients with Chagas disease at a referral center in Brazil
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2021-06-01)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
by: Marcelo Teixeira Holanda, et al.
Published: (2018-09-01)

Occurrence of Stroke and Reduced Ejection Fraction in Patients with Chagas Disease
by: Elieusa e Silva Sampaio, et al.

Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysis
by: Sindhu Chadalawada, et al.
Published: (2021-12-01)

Determinants of minute ventilation-carbon dioxide production relationship in Chagas cardiomyopathy
by: Lucas Frois Fernandes Oliveira, et al.
Published: (2021-11-01)

Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study
by: Mauro Felippe Felix Mediano, et al.
Published: (2016-06-01)

Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function
by: Whesley Tanor Silva, et al.
Published: (2020-11-01)

Ethiological treatment of acute and chronic Chagas' heart disease
by: Abílio Augusto Fragata Filho, et al.

Discussing the Score of Cardioembolic Ischemic Stroke in Chagas Disease
by: Fernanda de Souza Nogueira Sardinha Mendes, et al.
Published: (2020-05-01)

Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2020-05-01)

Chronic Heart Disease after Treatment of Oral Acute Chagas Disease
by: Andrei Fornanciari Antunes, et al.

CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy
by: Germano Carneiro Costa, et al.

The Burden of Chagas Disease in the Contemporary World: The RAISE Study
by: Antonio Luiz Pinho Ribeiro, et al.
Published: (2024-01-01)

Chagas Heart Disease: Beyond a Single Complication, from Asymptomatic Disease to Heart Failure
by: Isis G. Montalvo-Ocotoxtle, et al.
Published: (2022-12-01)

Reassessment of quality of life domains in patients with compensated Chagas heart failure after participating in a cardiac rehabilitation program
by: Mauro Felippe Felix Mediano, et al.

Estratégias de prevenção do acidente vascular encefálico cardioembólico na doença de Chagas Prevention strategies of cardioembolic ischemic stroke in Chagas' disease
by: Andréa Silvestre de Sousa, et al.
Published: (2008-11-01)

Indeterminate form of Chagas disease: historical, conceptual, clinical, and prognostic aspects
by: Alejandro Marcel Hasslocher-Moreno, et al.
Published: (2021-07-01)

Immunosuppressive drugs as a tool to explore immunopathology in experimental Chagas disease
by: KS Calabrese
Published: (1999-09-01)

Death due to acute Chagas -related myocarditis in a child: a case report
by: Theresa Cristina Cardoso da Silva, et al.
Published: (2020-04-01)

Serum cytokines in chronic Chagas' disease
by: Ward Laura S., et al.
Published: (1999-01-01)

Anatomopathological Aspects of Acute Chagas Myocarditis by Oral Transmission
by: Dilma do Socorro Moraes de Souza, et al.
Published: (2016-07-01)

Circulating microRNAs as biomarkers of Chagas cardiomyopathy
by: Laura Antonietti, et al.
Published: (2023-12-01)

Early identification of patients with Chagas disease at risk of developing cardiomyopathy using 2-D speckle tracking strain
by: Sithu Win, et al.
Published: (2022-08-01)

Acometimento cardíaco em Casos de Doença de Chagas Aguda da Amazônia Cardiac involvement in Acute Chagas' Disease Cases in the Amazon region
by: João Marcos Barbosa-Ferreira, et al.
Published: (2010-06-01)

The association of exercise test variables with long-term mortality in patients with chronic Chagas disease
by: Rudson S. Silva, et al.
Published: (2022-09-01)

Immunopathology of cardiomyopathy in the experimental Chagas disease
by: Milena BP Soares, et al.
Published: (1999-09-01)

Chagas Disease: From Discovery to a Worldwide Health Problem
by: Kárita Cláudia Freitas Lidani, et al.
Published: (2019-07-01)

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy
by: Luis E. Echeverría, et al.
Published: (2021-11-01)